ReviewTargeted therapy in cervical cancer
Cited by (0)
Contributors: CV collected the information that was used to write this manuscript. He wrote the first draft of the manuscript. SG conceived the structure and contents of the manuscript, reviewed all versions of the manuscript and undertook the revisions for subsequent drafts.
Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests: SG has the following disclosures: Institutional financial interests for conducted research: Roche, Sanofi, Johnson & Johnson, Amgen, Celltrion, Oncosten, Novartis, Intas, Eisai, Biocon. Non-remunerated activities—Advisory board: Roche, Sanofi, Dr. Reddy’s Laboratories, Biocon, Pfizer, Oncosten, Core Diagnostics. Leadership roles: Vice-President of the Indian Society of Medical and Paediatric Oncology. General Secretary of a non-governmental organisation ‘Women’s Cancer Institute—Tata Memorial Hospital’.
Patient consent for publication: Not required.
Provenance and peer review: Not commissioned; externally peer reviewed.